Guidant stent recall
This article was originally published in The Gray Sheet
Voluntary recall initiated of certain lots in the U.S., Europe and Australia following reports of 3.0 mm Multi-Link Vision becoming dislodged from delivery balloon in packaging. Implanted patients are unaffected. Guidant is working with U.S. and European regulatory bodies to replace the coronary stent systems, made in California and Ireland. According to the firm, the action will not affect its drug-eluting stent program, for which Vision is the platform...
You may also be interested in...
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.